Learn more

PROVIDENCE HEALTH & SERVICES OREGON

Overview
  • Total Patents
    40
  • GoodIP Patent Rank
    71,778
About

PROVIDENCE HEALTH & SERVICES OREGON has a total of 40 patent applications. Its first patent ever was published in 2006. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ISTITUTO SUPERIORE DI SANITO, TSUNODA TAKUYA and MEMORIAL SLOAN KETTERING CANCER CENTER.

Patent filings per year

Chart showing PROVIDENCE HEALTH & SERVICES OREGONs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Weinberg Andrew D 8
#2 Weinberg Andy 7
#3 Duhen Thomas 6
#4 Duhen Rebekka 6
#5 Montler Ryan 6
#6 Crittenden Marka 5
#7 Gough Michael 5
#8 Hu Hong-Ming 5
#9 Redmond William 4
#10 Jiao Jun 4

Latest patents

Publication Filing date Title
WO2021062033A1 Fusion polypeptides binding antibody fc domains and integrin and methods of use
WO2021050936A1 Methods of treatment with cd8 t cell-mediated immune therapy
US2019175709A1 Genetic expression of hla molecules to enhance immunotherapies
WO2019032560A1 Intestinal lengthening device
KR20200015717A Utilization of CD39 and CD103 for Identification of Human Tumor Reactive T Cells for Cancer Treatment
EP3268387A1 Compositions and methods for enhancing the efficacy of cancer therapy
US2017216420A1 Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof
AU2013263717A1 Trimeric OX40L-immunoglobulin fusion protein and methods of use
WO2013130102A2 Dual ox40 agonist/il-2 cancer therapy methods
EP2812022A1 Method of monitoring cancer treatment using ox40 agonists
AU2011265482A1 Trimeric OX40L-immunoglobulin fusion protein and methods of use
TW201309328A Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates
EP2608811A1 Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates